Volume 52, Issue 3, Pages (September 2007)

Slides:

Advertisements

Similar presentations

Volume 62, Issue 4, Pages (October 2012)

Advertisements

The PSA Era is not Over for Prostate Cancer

Volume 59, Issue 2, Pages (February 2011)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

Testosterone Therapy in Men With Prostate Cancer

Global Trends in Testicular Cancer Incidence and Mortality

Volume 56, Issue 6, Pages (December 2009)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 70, Issue 6, Pages (December 2016)

Volume 54, Issue 6, Pages (December 2008)

Volume 61, Issue 5, Pages (May 2012)

Volume 64, Issue 4, Pages (October 2013)

Volume 69, Issue 1, Pages (January 2016)

Let the Games Begin (with EAU Approval)

Volume 61, Issue 2, Pages (February 2012)

Prostate Cancer Epidemic in Sight?

Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer Olav Erich Yri, Trine Bjoro, Sophie D.

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 51, Issue 1, Pages (January 2007)

Volume 54, Issue 4, Pages (October 2008)

Volume 52, Issue 3, Pages (September 2007)

Volume 63, Issue 6, Pages (June 2013)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 62, Issue 3, Pages (September 2012)

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 68, Issue 3, Pages (September 2015)

Volume 56, Issue 2, Pages (August 2009)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 64, Issue 3, Pages (September 2013)

Counselling the Prostate Cancer Patient

Laurent Boccon-Gibod European Urology Supplements

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Volume 66, Issue 2, Pages (August 2014)

Volume 63, Issue 3, Pages (March 2013)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Volume 65, Issue 6, Pages (June 2014)

Tillmann Loch, Pat Fox Fulgham European Urology

Richard C. Harkaway European Urology Supplements

The Economic Costs of Overactive Bladder in Germany

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

The Importance of Testosterone Control in Prostate Cancer

Testicular Cancer Variations in Time and Space in Europe

Volume 53, Issue 1, Pages (January 2008)

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

European Urology is “Your” Journal

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.

Economic Burden of Bladder Cancer Across the European Union

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Volume 54, Issue 3, Pages (September 2008)

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 52, Issue 3, Pages 715-724 (September 2007) Prostate Cancer Distribution in Patients Diagnosed by Transperineal Template-Guided Saturation Biopsy Gregory S. Merrick, Sarah Gutman, Hugo Andreini, Walter Taubenslag, David L. Lindert, Rodney Curtis, Edward Adamovich, Richard Anderson, Zachariah Allen, Wayne Butler, Kent Wallner European Urology Volume 52, Issue 3, Pages 715-724 (September 2007) DOI: 10.1016/j.eururo.2007.02.041 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Number of transperineal template-guided saturation regional biopsy locations. European Urology 2007 52, 715-724DOI: (10.1016/j.eururo.2007.02.041) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 Distribution of prostate cancer diagnosed by saturation biopsy. European Urology 2007 52, 715-724DOI: (10.1016/j.eururo.2007.02.041) Copyright © 2007 European Association of Urology Terms and Conditions